Market Rank #13 · Evidence Tier A

Belgium
Neuroscience Intelligence

Belgium neuroscience intelligence: 175 indexed trials, 46 institutions, research score 37.30.

⚗
175Indexed trials
↗
41Recruiting
⌂
46Research institutions
◎
37.3Research score

Evidence profile

95Sponsors
23Disease areas
0Institution works
0Institution citations

Model signals

Opportunity 37 · ML priority 37 · Confidence 100 · Evidence 37.3

These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.

Leading disease areas

epilepsy23trials
alzheimers23trials
parkinsons18trials
stroke17trials
neuromuscular13trials
other_neurology10trials
multiple_sclerosis8trials
pain_neuropathy6trials
adhd6trials
migraine_headache4trials

Leading indexed sponsors

Hoffmann-La Roche10trials
University Hospital, Ghent9trials
Merck Sharp & Dohme LLC8trials
Cliniques universitaires Saint-Luc- Université Catholique de Louvain5trials
Universitair Ziekenhuis Brussel5trials
Novartis Pharmaceuticals5trials
Novo Nordisk A/S4trials
UCB Pharma4trials
Bayer4trials
AbbVie4trials